HansBiomed Corporation (KOSDAQ:A042520) announced a share repurchase program. Under the program, the company will repurchase up to KRW 3,000 million worth of its shares according to the contract with Shinhan Investment Corp. The purpose of the program is stabilization of stock prices and enhancement of shareholder value.

The program will expire on July 18, 2022. As of January 16, 2022, the company had 91,105 and 0 treasury stock holdings within the available dividend range acquisition and other acquisitions, respectively.